SenesTech to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
SenesTech, Inc. (NASDAQ: SNES) is set to release its financial results for the third quarter of 2022, ending September 30, 2022, on November 14, 2022, before market open. A conference call will follow at 11:00 am ET to discuss the findings. The company focuses on innovative pest control through its patented product, ContraPest, designed to manage rat populations sustainably. Stakeholders can access the call via phone or live webcast and will have a replay option for later review.
- Scheduled release of third quarter results may indicate transparency and commitment to shareholder communication.
- None.
Financial results to be released before market open; Conference call to be conducted at 11:00 am ET
PHOENIX, Nov. 9, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2022, ended September 30, 2022, before the market open on Monday, November 14, 2022. The Company has scheduled a conference call that same day, Monday, November 14, 2002, at 11:00 am ET, to review the results.
Third Quarter 2022 Conference Call Details
Date and Time: Monday, November 14, 2022, at 11:00 am ET
Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.
Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/.
Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 9489792. A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for 90 days.
About SenesTech
We are "The Pest Control Difference" for the 21st century. We are rodent fertility control specialists fueled by our passion to create a healthy environment by virtually eliminating rodent pest populations. We keep an inescapable truth in mind: 2 rats and their descendants can be responsible for the birth of up to 15,000 pups in a year. We invented ContraPest , the only U.S. EPA-registered contraceptive for male and female rats. ContraPest fits seamlessly into all integrated pest management programs, greatly improving the overall goal of effective rat management. We strive for clean cities, efficient businesses, and happy households – with a product that was designed to be effective and sustainable without killing rats. At SenesTech , we don't just eliminate rats. We make a better world.
For more information visit https://senestech.com/ and https://contrapeststore.com.
Safe Harbor Statement
The foregoing paragraphs contain forward-looking statements that involve estimates, assumptions, risks and uncertainties. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. "Forward-looking statements" may be preceded by words such as "may," "future," "plan" or "planned," "will," "should," "expected," "anticipates," "continue," "eventually," "believes," or "projected." Forward-looking statements include statements concerning the potential impact and effects of the COVID-19 pandemic on the Company's business, results of operations and financial performance; any measures the Company has and may take in response to COVID-19 and any expectations the Company may have with respect thereto; the Company's strategy and target marketing and markets; continuing the Company's vision; expected benefits of the Company's initiatives and continuation of those initiatives; deployment of the Company's product; the continuation or expansion of the use of ContraPest; demand for ContraPest; the Company's expectation regarding costs, expenses and cash and continuing its cost improvement plan; future financial results; and the Company's execution of its strategic business plan.
CONTACT:
Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-third-quarter-2022-financial-results-on-monday-november-14-2022-301673480.html
SOURCE SenesTech, Inc.
FAQ
When will SenesTech report its third quarter 2022 financial results?
What time is the SenesTech conference call scheduled?
How can I access the SenesTech conference call?
What is ContraPest?
